Hepatic hemangioma is a benign liver tumor, and the cause is usually related to congenital abnormal development, estrogen abnormalities, capillary infection and other factors. Most patients have no obvious clinical symptoms and should be reviewed regularly according to medical advice. If the tumor is 5-10 cm in diameter, increases rapidly within a short period of time, affects adjacent organs, or has imaging features that are not easily distinguishable from liver cancer, then corresponding treatment is needed: 1. 2. Surgical treatment: mainly includes hemangioma debridement, irregular liver resection and liver transplantation, which are more effective methods to treat hepatic hemangioma. Hepatic hemangioma debulking is more suitable for patients whose tumors are located in the periphery of the liver and away from the large intrahepatic vessels. For some patients who have difficulty in separating the gap between the liver parenchyma and the hemangioma, regular hepatectomy is suitable. If the patient suffers from diffuse hepatic hemangioma or has entered the terminal stage of the disease and cannot tolerate surgery or minimally invasive treatment, liver transplantation is suitable; 3. Minimally invasive treatment: mainly includes microwave curing or radiofrequency ablation treatment of hepatic hemangioma, arterial embolization of hepatic hemangioma (TAE) treatment, etc., which is suitable for patients with severe symptoms, coagulation disorders, combined malignant tumors, or older and weaker patients who cannot tolerate surgical procedures. Patients with severe symptoms, coagulation disorders, combined malignant tumors, or those who are too old or weak to undergo surgery.